Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
APGE | US
Overview
Corporate Details
- ISIN(s):
- US03770N1019
- LEI:
- Country:
- United States of America
- Address:
- 221 CRESCENT ST., 2453 WALTHAM
- Website:
- https://apogeetherapeutics.com/
- Sector:
- Manufacturing
Description
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company that develops differentiated biologics for immunological and inflammatory (I&I) diseases. The company's pipeline consists of novel antibody therapeutics targeting well-established biological pathways to treat conditions such as atopic dermatitis (AD), asthma, and chronic obstructive pulmonary disease (COPD), as well as other dermatological and respiratory disorders. Apogee's scientific approach focuses on creating therapies with the potential for improved efficacy and less frequent dosing, aiming to advance the standard of care for patients with these conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Apogee Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Apogee Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Apogee Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
